Nimml Institute Inc

EIN: 842520149 501(c)(3) Medical Research

Blacksburg, VA

Total Revenue
$232,448
Total Expenses
$440,651
Total Assets
$9,935
Net Assets
$9,935
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2019
Legal Domicile
VA
Principal Officer
Josep Bassaganya-Riera
Phone
5408182844
Tax Period
2024-01-01 to 2024-12-31

Nimml Institute Inc, founded in 2019, is a small nonprofit in the Medical Research sector that reported $232K in total revenue in fiscal year 2024. Revenue fell 59% from the prior year — a significant decline worth monitoring. Expenses of $441K exceeded revenue, resulting in a 90% operating deficit.

Mission

To comprehensively and systematically characterize mechanisms of action underlying infectious, metabolic and autoimmune diseases; the nimml institute will translate this new scientific knowledge to identify new therapeutic targets and develop innovative therapeutics for human diseases that are safer and more effective.

Program Service Accomplishments

Program 1
Expenses: $89,016 Revenue: $50,526

This program has resulted in substantial research and development progress achieved toward the advancement of the mechanisms of allergen- induced Type 2 immunity; to investigate the immunological...

Read more

This program has resulted in substantial research and development progress achieved toward the advancement of the mechanisms of allergen- induced Type 2 immunity; to investigate the immunological mechanisms that are involved in the development of Th2-type airway inflammation and allergen-specific igE antibodies in response to exposure to airborne allergens.

Program 2
Expenses: $315,604 Revenue: $181,914

Program goals were achieved by providing specialized data management and analysis, and protocol development services, to support ongoing research projects aimed at the investigation of mechanisms of...

Read more

Program goals were achieved by providing specialized data management and analysis, and protocol development services, to support ongoing research projects aimed at the investigation of mechanisms of action for development computational models of the immune response and developing new precision immunology therapeutics for human disease. NIMML provides expert planning and execution serviced designed to help reach organizations meet their therapeutic target goals.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $50,526
Program Service Revenue $181,914
Investment Income $8
Other Revenue $0
TOTAL REVENUE $232,448

Expense Breakdown

Grants Paid $0
Salaries & Benefits $132,650
Fundraising Expenses $0
Program Expenses $404,620
Other Expenses $308,001
TOTAL EXPENSES $440,651

Year-over-Year Comparison

2024 2023 Change
Revenue $232,448 $569,263 -0.6%
Expenses $440,651 $351,125 +0.3%
Net Income $-208,203 $218,138 -2.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
2
Employees
4
Volunteers
10

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Josep Bassaganya-Riera President, Director 5.00
Officer
$0 $0 $0
Raquel Hontecillas Director and CSO 5.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $232,448 $440,651 $9,935 $-208,203
2023 No data No data No data No data
2022 $536,440 $497,216 No data $39,224
2021 $5,308,304 $169,004 $5,268,074 $5,139,300
Explore More Nonprofits
Top 100 Nonprofits in Virginia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare Nimml Institute Inc with other nonprofits in Virginia and across the country.